Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New rapid test aims to spot COVID, flu, and RSV in minutes

NCT ID NCT05268939

First seen Jun 19, 2026 · Last updated Jun 19, 2026

Summary

This study tested two new rapid swab tests that can detect COVID-19, influenza A/B, and RSV from a single sample. Researchers enrolled 589 people with symptoms and compared the test results to standard lab methods. The goal was to see how accurate and easy the tests are to use at clinics and other point-of-care sites.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Benchmark Research

    Covington, Louisiana, 70433, United States

  • Clinical Research Solutions

    Middleburg Heights, Ohio, 44130, United States

  • Cullman Clinical Trials

    Cullman, Alabama, 35055, United States

  • Diagnamics, Inc

    Encinitas, California, 92024, United States

  • Excellence Medical and Research

    Miami Gardens, Florida, 33169, United States

  • Koch Family Medicine

    Morton, Illinois, 61550, United States

  • Machuca Foundation

    Las Vegas, Nevada, 89104, United States

  • Marisela Gonzalez, MD, PA

    Miami, Florida, 33155, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

LumiraDx SARS-CoV-2 & Flu A/B test and LumiraDx SARS-CoV-2 & RSV test (diagnostic swab tests)

What this could lead to

If successful, these tests could allow healthcare workers to quickly and accurately diagnose COVID-19, flu, or RSV at the point of care, helping guide treatment decisions.

What could go wrong

This is a completed study evaluating test accuracy, not a treatment. The tests may not be as accurate as lab-based methods, and results depend on proper sample collection and timing.

Conditions

The condition(s) this trial relates to.

COVID-19 influenza respiratory syncytial virus infectious disease swine influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.